Skip to content

SPRING Clinical Trial Update

22/11/2024

Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.

Read More